Acoustically driven bubbles produce a range of mechanical, thermal and chemical effects that can be exploited in drug delivery applications. Significant improvements in the targeting, distribution and efficacy of both current and emerging therapeutics can be achieved, from small molecules to biologics and nucleic-acid-based drugs. This Review describes how specially designed cavitation nuclei in the form of solid, liquid or gas particles can enable the triggered release of drugs, promote the permeabiliziation of challenging biological barriers and enhance drug delivery through tissue regions where diffusion alone is inadequate. Scalable strategies for mapping and controlling cavitation activity to harness its therapeutic potential at depth within the body are discussed, alongside current and emerging applications for the treatment of diseases, including cancer and stroke.
A major challenge in the treatment of diseases such as cancer and stroke is achieving a sufficient concentration of a drug throughout the target region without producing toxic side effects elsewhere in the body.
Oscillating microbubbles driven by ultrasound produce a range of mechanical, thermal and chemical effects that can be used to enable both localized delivery and improved distribution of drugs in tissue.
This approach can be used to deliver both conventional small-molecule drugs and more recent biological therapeutics to areas of the body that are normally inaccessible, including across the blood–brain barrier and into solid tumours.
Ultrasound-responsive microparticles and nanoparticles can either be used as drug carriers or co-administered with a free drug into the bloodstream, providing cavitation nuclei that reduce the ultrasound pressures required to achieve effective drug delivery.
The production of strong acoustic emissions during cavitation-enhanced delivery enables acoustic localization and mapping of bubble activity in real time for treatment monitoring.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Lohse, D., Schmitz, B. & Versluis, M. Snapping shrimp make flashing bubbles. Nature 413, 477–478 (2001).
Suslick, K. S. Sonochemistry. Science 247, 1439–1445 (1990).
Mitragotri, S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discov. 4, 255–260 (2005).
Lehmann, J. F. & Herrick, J. F. Biologic reactions to cavitation, a consideration for ultrasonic therapy. Arch. Phys. Med. Rehabil. 34, 86–98 (1953).
Nyborg, W. L. Biological effects of ultrasound: development of safety guidelines. Part II: general review. Ultrasound Med. Biol. 27, 301–333 (2001).
Crum, L. A. Cavitation microjets as a contributory mechanism for renal calculi disintegration in ESWL. J. Urol. 140, 1587–1590 (1988).
Kennedy, J. E. High-intensity focused ultrasound in the treatment of solid tumours. Nat. Rev. Cancer 5, 321–327 (2005).
Fechheimer, M. et al. Transfection of mammalian-cells with plasmid DNA by scrape loading and sonication loading. Proc. Natl Acad. Sci. USA 84, 8463–8467 (1987).
McDannold, N., Vykhodtseva, N. & Hynynen, K. Targeted disruption of the blood–brain barrier with focused ultrasound: association with cavitation activity. Phys. Med. Biol. 51, 793–807 (2006).
Langer, R. Drug delivery and targeting. Nature 392 (Suppl.), 5–10 (1998).
Husseini, G. A. & Pitt, W. G. Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv. Drug Deliv. Rev. 60, 1137–1152 (2008).
Evjen, T. J. et al. In vivo monitoring of liposomal release in tumours following ultrasound stimulation. Eur. J. Pharm. Biopharm. 84, 526–531 (2013).
Graham, S. M. et al. Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes. J. Control. Release 178, 101–107 (2014).
Kolb, J. & Nyborg, W. L. Small-scale acoustic streaming in liquids. J. Acoust. Soc. Am. 28, 1237–1242 (1956).
Nyborg, W. L. Acoustic streaming near a boundary. J. Acoust. Soc. Am. 30, 329–339 (1958).
Elder, S. & Nyborg, W. L. Acoustic streaming resulting from a resonant bubble. J. Acoust. Soc. Am. 28, 155–155 (1956).
Marmottant, P. & Hilgenfeldt, S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 423, 153–156 (2003).
Jia, C. et al. Generation of reactive oxygen species in heterogeneously sonoporated cells by microbubbles with single-pulse ultrasound. Ultrasound Med. Biol. 44, 1074–1085 (2018).
Nce, A. On the mechanism of cavitation damage by nonhemispherical cavities collapsing in contact with a solid boundary. J. Basic Eng. 83, 648–656 (1961).
Benjamin, T. B. & Ellis, A. T. The collapse of cavitation bubbles and the pressures thereby produced against solid boundaries. Phil. Trans. R. Soc. Lond. A 260, 221–240 (1966).
Enayati, M., Al Mohazey, D., Edirisinghe, M. & Stride, E. Ultrasound-stimulated drug release from polymer micro and nanoparticles. Bioinspir. Biomim. Nanobiomater. 2, 3–10 (2013).
Ahmed, S. E., Martins, A. M. & Husseini, G. A. The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes. J. Drug Target. 23, 16–42 (2015).
Hilgenfeldt, S., Lohse, D. & Zomack, M. Response of bubbles to diagnostic ultrasound: a unifying theoretical approach. Eur. Phys. J. B 4, 247–255 (1998).
Holt, R. G. & Roy, R. A. Measurements of bubble-enhanced heating from focused, MHz-frequency ultrasound in a tissue-mimicking material. Ultrasound Med. Biol. 27, 1399–1412 (2001).
Hilgenfeldt, S. & Lohse, D. The acoustics of diagnostic microbubbles: dissipative effects and heat deposition. Ultrasonics 38, 99–104 (2000).
Hilgenfeldt, S., Lohse, D. & Zomack, M. Sound scattering and localized heat deposition of pulse-driven microbubbles. J. Acoust. Soc. Am. 107, 3530–3539 (2000).
Yudina, A. et al. Ultrasound-mediated intracellular drug delivery using microbubbles and temperature-sensitive liposomes. J. Control. Release 155, 442–448 (2011).
Coussios, C. C. & Roy, R. A. Applications of acoustics and cavitation to noninvasive therapy and drug delivery. Annu. Rev. Fluid Mech. 40, 395–420 (2008).
Bader, K. B., Gruber, M. J. & Holland, C. K. Shaken and stirred: mechanisms of ultrasound-enhanced thrombolysis. Ultrasound Med. Biol. 41, 187–196 (2015).
Miller, D. L., Thomas, R. M. & Williams, A. R. Mechanisms for hemolysis by ultrasonic cavitation in the rotating exposure system. Ultrasound Med. Biol. 17, 171–178 (1991).
Prosperetti, A. Thermal effects and damping mechanisms in forced radial oscillations of gas-bubbles in liquids. J. Acoust. Soc. Am. 61, 17–27 (1977).
Flint, E. B. & Suslick, K. S. The temperature of cavitation. Science 253, 1397–1399 (1991).
Winterbourn, C. C. Reconciling the chemistry and biology of reactive oxygen species. Nat. Chem. Biol. 4, 278–286 (2008).
Kudo, N. & Kinoshita, Y. Effects of cell culture scaffold stiffness on cell membrane damage induced by sonoporation. J. Med. Ultrason. 41, 411–420 (2014).
McEwan, C. et al. Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle. Biomaterials 80, 20–32 (2016).
Lee, J. Y. et al. Ultrasound-enhanced siRNA delivery using magnetic nanoparticle-loaded chitosan-deoxycholic acid nanodroplets. Adv. Healthc. Mater. 6, 1601246 (2017).
Rosenthal, I., Sostaric, J. Z. & Riesz, P. Sonodynamic therapy — a review of the synergistic effects of drugs and ultrasound. Ultrason. Sonochem. 11, 349–363 (2004).
Bohmer, M. R. et al. Focused ultrasound and microbubbles for enhanced extravasation. J. Control. Release 148, 18–24 (2010).
Carlisle, R. & Coussios, C.-C. Mechanical approaches to oncological drug delivery. Ther. Deliv. 4, 1213–1215 (2013).
Arvanitis, C. D., Bazan-Peregrino, M., Rifai, B., Seymour, L. W. & Coussios, C. C. Cavitation-enhanced extravasation for drug delivery. Ultrasound Med. Biol. 37, 1838–1852 (2011).
Carlisle, R. et al. Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound. J. Natl Cancer Inst. 105, 1701–1710 (2013).
Rifai, B., Arvanitis, C. D., Bazan-Peregrino, M. & Coussios, C. C. Cavitation-enhanced delivery of macromolecules into an obstructed vessel. J. Acoust. Soc. Am. 128, El310–El315 (2010).
van Wamel, A. et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J. Control. Release 112, 149–155 (2006).
Kudo, N. High-speed in situ observation system for sonoporation of cells with size- and position-controlled microbubbles. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 64, 273–280 (2017).
Abbott, N. J. Blood–brain barrier structure and function and the challenges for CNS drug delivery. J. Inherit. Metab. Dis. 36, 437–449 (2013).
Kooiman, K., van der Steen, A. F. & de Jong, N. Role of intracellular calcium and reactive oxygen species in microbubble-mediated alterations of endothelial layer permeability. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 60, 1811–1815 (2013).
Juffermans, L. J., Kamp, O., Dijkmans, P. A., Visser, C. A. & Musters, R. J. Low-intensity ultrasound-exposed microbubbles provoke local hyperpolarization of the cell membrane via activation of BK(Ca) channels. Ultrasound Med. Biol. 34, 502–508 (2008).
Helfield, B. L., Chen, X. C., Qin, B., Watkins, S. C. & Villanueva, F. S. Mechanistic insight into sonoporation with ultrasound-stimulated polymer microbubbles. Ultrasound Med. Biol. 43, 2678–2689 (2017).
Acconcia, C. N., Leung, B. Y. & Goertz, D. E. The microscale evolution of the erosion front of blood clots exposed to ultrasound stimulated microbubbles. J. Acoust. Soc. Am. 139, EL135–EL141 (2016).
Caskey, C. F., Qin, S., Dayton, P. A. & Ferrara, K. W. Microbubble tunneling in gel phantoms. J. Acoust. Soc. Am. 125, EL183–EL189 (2009).
Samiotaki, G. & Konofagou, E. E. Dependence of the reversibility of focused- ultrasound-induced blood-brain barrier opening on pressure and pulse length in vivo. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 60, 2257–2265 (2013).
Plesset, M. S. & Prosperetti, A. Bubble dynamics and cavitation. Annu. Rev. Fluid Mech. 9, 145–185 (1977).
Lajoinie, G. et al. Non-spherical oscillations drive the ultrasound-mediated release from targeted microbubbles. Commun. Phys. 1, 22 (2018).
Chen, H., Brayman, A. A., Kreider, W., Bailey, M. R. & Matula, T. J. Observations of translation and jetting of ultrasound-activated microbubbles in mesenteric microvessels. Ultrasound Med. Biol. 37, 2139–2148 (2011).
Martynov, S., Kostson, E., Saffari, N. & Stride, E. Forced vibrations of a bubble in a liquid-filled elastic vessel. J. Acoust. Soc. Am. 130, 2700–2708 (2011).
Chen, X., Wang, J., Pacella, J. J. & Villanueva, F. S. Dynamic behavior of microbubbles during long ultrasound tone-burst excitation: mechanistic insights into ultrasound-microbubble mediated therapeutics using high-speed imaging and cavitation detection. Ultrasound Med. Biol. 42, 528–538 (2016).
Lentacker, I., De Cock, I., Deckers, R., De Smedt, S. C. & Moonen, C. T. Understanding ultrasound induced sonoporation: definitions and underlying mechanisms. Adv. Drug Deliv. Rev. 72, 49–64 (2014).
Qin, P., Han, T., Yu, A. C. H. & Xu, L. Mechanistic understanding the bioeffects of ultrasound-driven microbubbles to enhance macromolecule delivery. J. Control. Release 272, 169–181 (2018).
Hebdm, W. Bubble formation in animals. J. Cell. Comp. Physiol. 24, 1–22 (1944).
Briggs, L. J. Limiting negative pressure of water. J. Appl. Phys. 21, 721–722 (1950).
Morch, K. A. Cavitation inception from bubble nuclei. Interface Focus 5, 20150006 (2015).
Strasberg, M. Onset of ultrasonic cavitation in tap water. J. Acoust. Soc. Am. 31, 163–176 (1959).
Atchley, A. A. & Prosperetti, A. The crevice model of bubble nucleation. J. Acoust. Soc. Am. 86, 1065–1084 (1989).
Borkent, B. M., Gekle, S., Prosperetti, A. & Lohse, D. Nucleation threshold and deactivation mechanisms of nanoscopic cavitation nuclei. Phys. Fluids 21, 102003 (2009).
Fox, F. E. & Herzfeld, K. F. Gas bubbles with organic skin as cavitation nuclei. J. Acoust. Soc. Am. 26, 984–989 (1954).
Yount, D. E. Skins of varying permeability — stabilization mechanism for gas cavitation nuclei. J. Acoust. Soc. Am. 65, 1429–1439 (1979).
Blake, F. G. Technical Memo. 12 (Acoustics Research Laboratory, Harvard University, 1949).
Hsieh, D. Y. & Plesset, M. S. Theory of rectified diffusion of mass into gas bubbles. J. Acoust. Soc. Am. 33, 206–20 (1961).
Church, C. C. The effects of an elastic solid-surface layer on the radial pulsations of gas-bubbles. J. Acoust. Soc. Am. 97, 1510–1521 (1995).
Carugo, D. et al. Modulation of the molecular arrangement in artificial and biological membranes by phospholipid-shelled microbubbles. Biomaterials 113, 105–117 (2017).
Lentacker, I., De Smedt, S. C. & Sanders, N. N. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter 5, 2161–2170 (2009).
Mulvana, H. et al. Characterization of contrast agent microbubbles for ultrasound imaging and therapy research. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 64, 232–251 (2017).
Tinkov, S. et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J. Control. Release 148, 368–372 (2010).
Geers, B. et al. Self-assembled liposome-loaded microbubbles: the missing link for safe and efficient ultrasound triggered drug-delivery. J. Control. Release 152, 249–256 (2011).
Geers, B., Dewitte, H., De Smedt, S. C. & Lentacker, I. Crucial factors and emerging concepts in ultrasound-triggered drug delivery. J. Control. Release 164, 248–255 (2012).
Vlaskou, D. et al. Magnetic microbubbles: magnetically targeted and ultrasound-triggered vectors for gene delivery in vitro. Hum. Gene Ther. 21, 1191–1191 (2010).
Sheng, Y. J. et al. Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer. J. Control. Release 262, 192–200 (2017).
McEwan, C. et al. Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours. J. Control. Release 203, 51–56 (2015).
Grishenkov, D. et al. Ultrasound contrast agent loaded with nitric oxide as a theranostic microdevice. Drug Des. Dev. Ther. 9, 2409–2419 (2015).
Morel, D. R. et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest. Radiol. 35, 80–85 (2000).
Rapoport, N., Gao, Z. & Kennedy, A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl Cancer Inst. 99, 1095–1106 (2007).
Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).
Sheeran, P. S., Luois, S., Dayton, P. A. & Matsunaga, T. O. Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir 27, 10412–10420 (2011).
Javadi, M., Pitt, W. G., Belnap, D. M., Tsosie, N. H. & Hartley, J. M. Encapsulating nanoemulsions inside eLiposomes for ultrasonic drug delivery. Langmuir 28, 14720–14729 (2012).
Wang, C. H. et al. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 33, 1939–1947 (2012).
Yu, J. S. et al. Echogenic chitosan nanodroplets for spatiotemporally controlled gene delivery. J. Biomed. Nanotechnol. 14, 1287–1297 (2018).
Moyer, L. C. et al. High-intensity focused ultrasound ablation enhancement in vivo via phase-shift nanodroplets compared to microbubbles. J. Ther. Ultrasound 3, 7 (2015).
Ho, Y. J. & Yeh, C. K. Theranostic performance of acoustic nanodroplet vaporization-generated bubbles in tumor intertissue. Theranostics 7, 1477–1488 (2017).
Chen, C. C. et al. Targeted drug delivery with focused ultrasound-induced blood–brain barrier opening using acoustically-activated nanodroplets. J. Control. Release 172, 795–804 (2013).
Sheeran, P. S., Matsunaga, T. O. & Dayton, P. A. Phase-transition thresholds and vaporization phenomena for ultrasound phase-change nanoemulsions assessed via high-speed optical microscopy. Phys. Med. Biol. 58, 4513–4534 (2013).
Shpak, O,. et al. Acoustic droplet vaporization is initiated by superharmonic focusing. Proc. Natl Acad. Sci. USA 111, 1697–1702 (2014).
Wang, Y. et al. Stable encapsulated air nanobubbles in water. Angew. Chem. Int. Ed. 54, 14291–14294 (2015).
Hernandez, C., Nieves, L., de Leon, A. C., Advincula, R. & Exner, A. A. Role of surface tension in gas nanobubble stability under ultrasound. ACS Appl. Mater. Interfaces 10, 9949–9956 (2018).
Paris, J. L. et al. Ultrasound-mediated cavitation-enhanced extravasation of mesoporous silica nanoparticles for controlled-release drug delivery. Chem. Eng. J. 340, 2–8 (2018).
Delogu, L. G. et al. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proc. Natl Acad. Sci. USA 109, 16612–16617 (2012).
Straub, J. A. et al. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J. Control. Release 108, 21–32 (2005).
Kwan, J. et al. Ultrasound-induced inertial cavitation from gas-stabilizing nanoparticles. Phys. Rev. E 92, 023019 (2015).
Mannaris, C. et al. Gas-stabilizing gold nanocones for acoustically mediated drug delivery. Adv. Healthc. Mater. 7, 1800184 (2018).
Kang, E. et al. Nanobubbles from gas-generating polymeric nanoparticles: ultrasound imaging of living subjects. Angew. Chem. Int. Ed. 49, 524–528 (2010).
Toyokuni, S. Genotoxicity and carcinogenicity risk of carbon nanotubes. Adv. Drug Deliv. Rev. 65, 2098–2110 (2013).
Prosperetti, A., Crum, L. A. & Commander, K. W. Nonlinear bubble dynamics. J. Acoust. Soc. Am. 83, 502–514 (1988).
Flynn, H. G. Cavitation dynamics. 2. Free pulsations and models for cavitation bubbles. J. Acoust. Soc. Am. 58, 1160–1170 (1975).
Church, C. C. & Carstensen, E. L. “Stable” inertial cavitation. Ultrasound Med. Biol. 27, 1435–1437 (2001).
Neppiras, E. A. Acoustic cavitation. Phys. Rep. 61, 159–251 (1980).
Apfel, R. E. & Holland, C. K. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med. Biol. 17, 179–185 (1991).
Madanshetty, S. I., Roy, R. & Apfel, R. E. Acoustic microcavitation: its active and passive acoustic detection. J. Acoust. Soc. Am. 90, 1515–1526 (1991).
Rabkin, B. A., Zderic, V. & Vaezy, S. Hyperecho in ultrasound images of HIFU therapy: involvement of cavitation. Ultrasound Med. Biol. 31, 947–956 (2005).
Coussios, C. C., Farny, C. H., Haar, G. T. & Roy, R. A. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Int. J. Hyperthermia 23, 105–120 (2007).
Arnal, B., Baranger, J., Demene, C., Tanter, M. & Pernot, M. In vivo real-time cavitation imaging in moving organs. Phys. Med. Biol. 62, 843–857 (2017).
Gateau, J., Aubry, J.-F., Pernot, M., Fink, M. & Tanter, M. Combined passive detection and ultrafast active imaging of cavitation events induced by short pulses of high-intensity ultrasound. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 58, 517–532 (2011).
Rabkin, B. A., Zderic, V., Crum, L. A. & Vaezy, S. Biological and physical mechanisms of HIFU-induced hyperecho in ultrasound images. Ultrasound Med. Biol. 32, 1721–1729 (2006).
Gyongy, M., Arora, M., Noble, J. A. & Coussios, C. C. Use of passive arrays for characterization and mapping of cavitation activity during HIFU exposure. In 2008 IEEE Ultrasonics Symposium 871–874 (IEEE, 2008).
Gyongy, M. & Coussios, C. C. Passive spatial mapping of inertial cavitation during HIFU exposure. IEEE Trans. Biomed. Eng. 57, 48–56 (2010).
Salgaonkar, V. A., Datta, S., Holland, C. K. & Mast, T. D. Passive cavitation imaging with ultrasound arrays. J. Acoust. Soc. Am. 126, 3071–3083 (2009).
Haworth, K. J. et al. Passive imaging with pulsed ultrasound insonations. J. Acoust. Soc. Am. 132, 544–553 (2012).
Arvanitis, C. D., Crake, C., McDannold, N. & Clement, G. T. Passive acoustic mapping with the angular spectrum method. IEEE Trans. Med. Imaging 36, 983–993 (2017).
Gyongy, M. & Coussios, C. C. Passive cavitation mapping for localization and tracking of bubble dynamics. J. Acoust. Soc. Am. 128, E175–E180 (2010).
Jensen, C. R. et al. Spatiotemporal monitoring of high-intensity focused ultrasound therapy with passive acoustic mapping. Radiology 262, 252–261 (2012).
Gray, M. D., Lyka, E. & Coussios, C. C. Diffraction effects and compensation in passive acoustic mapping. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 65, 258–268 (2018).
Coviello, C. et al. Passive acoustic mapping utilizing optimal beamforming in ultrasound therapy monitoring. J. Acoust. Soc. Am. 137, 2573–2585 (2015).
Choi, J. J., Carlisle, R. C., Coviello, C., Seymour, L. & Coussios, C.-C. Non-invasive and real-time passive acoustic mapping of ultrasound-mediated drug delivery. Phys. Med. Biol. 59, 4861–4877 (2014).
Kwan, J. J. et al. Ultrasound-propelled nanocups for drug delivery. Small 11, 5305–5314 (2015).
Miller, D. L. Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Prog. Biophys. Mol. Biol. 93, 314–330 (2007).
Hobbs, S. K. et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl Acad. Sci. USA 95, 4607–4612 (1998).
Bazan-Peregrino, M., Arvanitis, C. D., Rifai, B., Seymour, L. W. & Coussios, C. C. Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model. J. Control. Release 157, 235–242 (2012).
Bazan-Peregrino, M. et al. Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound. J. Control. Release 169, 40–47 (2013).
Lafond, M., Aptel, F., Mestas, J. L. & Lafon, C. Ultrasound-mediated ocular delivery of therapeutic agents: a review. Expert Opin. Drug Deliv. 14, 539–550 (2017).
Prieur, F. et al. Enhancement of fluorescent probe penetration into tumors in vivo using unseeded inertial cavitation. Ultrasound Med. Biol. 42, 1706–1713 (2016).
Li, T. et al. Pulsed high intensity focused ultrasound (pHIFU) enhances delivery of doxorubicin in a preclinical model of pancreatic cancer. Cancer Res. 75, 3738–3746 (2015).
Myers, R. et al. Polymeric cups for cavitation-mediated delivery of oncolytic vaccinia virus. Mol. Ther. 24, 1627–1633 (2016).
Dimcevski, G. et al. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. J. Control. Release 243, 172–181 (2016).
Hynynen, K., McDannold, N., Vykhodtseva, N. & Jolesz, F. A. Noninvasive MR imaging-guided focal opening of the blood–brain barrier in rabbits. Radiology 220, 640–646 (2001).
McDannold, N., Vykhodtseva, N. & Hynynen, K. Targeted disruption of the blood–brain barrier with focused ultrasound: association with cavitation activity. Phys. Med. Biol. 51, 793–807 (2006).
Tung, Y.-S. et al. In vivo transcranial cavitation threshold detection during ultrasound-induced blood–brain barrier opening in mice. Phys. Med. Biol. 55, 6141–6155 (2010).
Arvanitis, C. D., Livingstone, M. S. & McDannold, N. Combined ultrasound and MR imaging to guide focused ultrasound therapies in the brain. Phys. Med. Biol. 58, 4749–4761 (2013).
Jones, R. M. et al. Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood–brain barrier opening. Theranostics 8, 2909–2926 (2018).
Carpentier, A. et al. Clinical trial of blood–brain barrier disruption by pulsed ultrasound. Sci. Transl. Med. 8, 343re2 (2016).
Lipsman, N. et al. Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound. Nat. Commun. 9, 2336 (2018).
de Saint Victor, M., Crake, C., Coussios, C.-C. & Stride, E. Properties, characteristics and applications of microbubbles for sonothrombolysis. Expert Opin. Drug Deliv. 11, 187–209 (2014).
Mercado-Shekhar, K. P. et al. Effect of clot stiffness on recombinant tissue plasminogen activator lytic susceptibility in vitro. Ultrasound Med. Biol. 44, 2710–2727 (2018).
Datta, S. et al. Ultrasound-enhanced thrombolysis using Definity® as a cavitation nucleation agent. Ultrasound Med. Biol. 34, 1421–1433 (2008).
Datta, S. et al. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med. Biol. 32, 1257–1267 (2006).
Molina, C. A. et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 37, 425–429 (2006).
Mathias, W. et al. The effectiveness of microbubble-mediated sonothrombolysis for inducing early recanalization of different culprit coronary arteries in patients with acute ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 71, A1460 (2018).
Mathias, W. et al. Diagnostic ultrasound impulses improve microvascular flow in patients with STEMI receiving intravenous microbubbles. J. Am. Coll. Cardiol. 67, 2506–2515 (2016).
Molina, C. A. et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann. Neurol. 66, 28–38 (2009).
Owen, J. et al. Magnetic targeting of microbubbles against physiologically relevant flow conditions. Interface Focus 5, 20150001 (2015).
Vignon, F. et al. Microbubble cavitation imaging. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 60, 661–670 (2013).
Qiao, S., Coussios, C. & Cleveland, R. Characterization of modular arrays for transpinal ultrasound application. J. Acoust. Soc. Am. 141, 3954–3954 (2017).
Fletcher, S.-M. P. & O’Reilly, M. A. Analysis of multi-frequency and phase keying strategies for focusing ultrasound to the human vertebral canal. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 65, 2322–2331 (2018).
O’Reilly, M. A. et al. Preliminary investigation of focused ultrasound-facilitated drug delivery for the treatment of leptomeningeal metastases. Sci. Rep. 8, 9013 (2018).
Mitragotri, S., Edwards, D. A., Blankschtein, D. & Langer, R. Mechanistic study of ultrasonically-enhanced transdermal drug-delivery. J. Pharm. Sci. 84, 697–706 (1995).
Tezel, A., Paliwal, S., Shen, Z. & Mitragotri, S. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 23, 3800–3807 (2005).
Polat, B. E., Hart, D., Langer, R. & Blankschtein, D. Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J. Control. Release 152, 330–348 (2011).
Mitragotri, S., Blankschtein, D. & Langer, R. Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 13, 411–420 (1996).
Tezel, A., Sens, A., Tuchscherer, J. & Mitragotri, S. Frequency dependence of sonophoresis. Pharm. Res. 18, 1694–1700 (2001).
Tezel, A., Sens, A. & Mitragotri, S. Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J. Pharm. Sci. 91, 444–453 (2002).
Tezel, A. & Mitragotri, S. Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys. J. 85, 3502–3512 (2003).
Rich, K. T., Hoerig, C. L., Rao, M. B. & Mast, T. D. Relations between acoustic cavitation and skin resistance during intermediate-and high-frequency sonophoresis. J. Control. Release 194, 266–277 (2014).
Bhatnagar, S., Schiffter, H. & Coussios, C. C. Exploitation of acoustic cavitation-induced microstreaming to enhance molecular transport. J. Pharm. Sci. 103, 1903–1912 (2014).
Bhatnagar, S., Kwan, J. J., Shah, A. R., Coussios, C. C. & Carlisle, R. C. Exploitation of sub-micron cavitation nuclei to enhance ultrasound-mediated transdermal transport and penetration of vaccines. J. Control. Release 238, 22–30 (2016).
Feiszthuber, H., Bhatnagar, S., Gyöngy, M. & Coussios, C.-C. Cavitation-enhanced delivery of insulin in agar and porcine models of human skin. Phys. Med. Biol. 60, 2421–2434 (2015).
Tran, D. M. et al. Prolonging pulse duration in ultrasound-mediated gene delivery lowers acoustic pressure threshold for efficient gene transfer to cells and small animals. J. Control. Release 279, 345–354 (2018).
Lee, J. Y. et al. Nanoparticle-loaded protein-polymer nanodroplets for improved stability and conversion efficiency in ultrasound imaging and drug delivery. Adv. Mater. 27, 5484–5492 (2015).
Haworth, K. J., Bader, K. B., Rich, K. T., Holland, C. K. & Mast, T. D. Quantitative frequency-domain passive cavitation imaging. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 64, 177–191 (2017).
Lu, S. et al. Passive acoustic mapping of cavitation using eigenspace-based robust Capon beamformer in ultrasound therapy. Ultrason. Sonochem. 41, 670–679 (2018).
Hockham, N., Coussios, C. C. & Arora, M. A real-time controller for sustaining thermally relevant acoustic cavitation during ultrasound therapy. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 57, 2685–2694 (2010).
O’Reilly, M. A. & Hynynen, K. Blood–brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions–based controller. Radiology 263, 96–106 (2012).
Deng, L., O’Reilly, M. A., Jones, R. M., An, R. & Hynynen, K. A multi-frequency sparse hemispherical ultrasound phased array for microbubble-mediated transcranial therapy and simultaneous cavitation mapping. Phys. Med. Biol. 61, 8476–8501 (2016).
The authors thank The Engineering and Physical Sciences Research Council for supporting their work through grants EP/ EP/L024012/1 and EP/L024012.
C.C. is a named inventor on several patents pertaining to cavitation nucleation, mapping, monitoring and control, and a founder, director, shareholder and consultant receiving consultancy income from OxSonics Ltd, a spin-out from the University of Oxford developing a commercial product to enable the clinical translation of cavitation-mediated drug delivery. E.S. is a named inventor on two patents relating to the use of microbubbles for therapeutic applications and a founder of SonoTarg Ltd, a spin-out company developing oxygen-loaded microbubbles for cancer treatment.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A medical procedure involving the physical destruction of solid masses such as kidney stones.
- High-intensity focused ultrasound
In medicine, this refers to ultrasound with intensities typically exceeding 1,000 W cm−2 used for thermal ablation of tissue, for example, for cancer treatment.
Relating to vessels, typically blood vessels.
The layer of cells lining the interior surface of blood or lymphatic vessels.
The microscale circulation of a viscous fluid produced by an oscillating structure.
- Tissue phantoms
Synthetic objects whose physical properties are similar to those of tissue, enabling experiments to be conducted in a realistic environment.
A process by which material is transported through the interior of a cell by encapsulation within vesicles that are formed on one side of the cell and ejected on the other.
- Secondary radiation force
The force generated between two objects as a result of their oscillation, which may be attractive or repulsive.
Ability to produce strong echoes — reflections or scattering — of an incident ultrasound field.
- Superharmonic focusing
The process by which a small acoustically responsive object acts as a lens focusing the high-frequency components of a nonlinearly propagated ultrasound wave.
The leakage of a fluid out of its container; in the context of drug delivery, the transport of material out of the bloodstream into the surrounding tissue.
To combine signals with suitable delays to amplify information coming from the region of interest.
- Stromal layer
A region of tissue containing cells that are not part of the specific function of the organ in which they reside. In a tumour, this layer consists of cells that are not themselves malignant but present a dense barrier to the diffusion of drugs.
Red blood cell whose primary function is the transport of oxygen throughout the bloodstream.
Referring to restricted blood supply and hence a shortage of oxygen.
The process of restoring flow to a blocked vessel.
Referring to the membrane constituting the outer layer of the heart.
- Langerhans cells
Immune cells present in all layers of the epidermis and stimulated during vaccination.
About this article
Cite this article
Stride, E., Coussios, C. Nucleation, mapping and control of cavitation for drug delivery. Nat Rev Phys 1, 495–509 (2019). https://doi.org/10.1038/s42254-019-0074-y